AGP Wire
Stay informed with articles highlighting the latest developments, major events, and essential updates.
ADZYNMA market study sees rare-disease demand and regional growth ahead
AGP
The Business Research Company says the global ADZYNMA market is set for a new growth phase through 2035, driven by rare-disease awareness, genetic screening and broader access to targeted therapies.
Adlyxin market forecast points to faster growth in Asia-Pacific
AGP
The Business Research Company says the global Adlyxin (Lyxumia) market is expanding as type 2 diabetes and obesity rates rise, with North America leading in 2025 and Asia-Pacific set for the fastest growth through 2035. The report also highlights…
ProSource urges businesses to close cybersecurity gaps as awareness month ends
AGP
ProSource is pushing businesses to reassess IT security controls as Cybersecurity Awareness Month wraps up Oct. 31, with a focus on five risk areas that can expose operations to attacks and outages.
Adcetris market seen growing to $2.12 million by 2030
AGP
The Business Research Company says the global Adcetris market is expanding on rising cancer cases, demand for targeted therapies and broader use in oncology.
Addiction rehab facilities market seen climbing to $33.1 billion by 2030
AGP
The Business Research Company says the global addiction rehab facilities market is growing on rising substance use disorder rates, better insurance coverage and expanding treatment options.
Acute pharyngitis market seen reaching $4.25 billion by 2030
AGP
The acute pharyngitis market is projected to rise from $2.89 billion in 2025 to $3.13 billion in 2026, with The Business Research Company forecasting $4.25 billion by 2030. Rising influenza and respiratory infections, along with telemedicine and…
Acute spinal cord injury market seen reaching $9.4 billion by 2030
AGP
The acute spinal cord injury market is projected to grow from $7.43 billion in 2026 to $9.4 billion by 2030, according to The Business Research Company.
OptimusDesk launches AI workspace for small businesses
AGP
OptimusPhil.io has launched OptimusDesk, a web-based business management platform that combines customers, projects, team collaboration and an AI assistant in one workspace.
Adrenal cancer diagnostics market to reach $206.14 billion by 2030
AGP
The Business Research Company projects the adrenal cancer diagnostics market will grow from $157.36 billion in 2026 to $206.14 billion by 2030, driven by imaging advances, targeted therapies and broader use of PET-CT scans.
Advate market forecast points to stronger demand through 2035
AGP
The Business Research Company says the Advate market will keep expanding through 2035, driven by rising hemophilia A diagnoses, broader use of prophylactic therapy, and growing preference for home-based care.
Adbry/Adtralza market seen growing through 2030 on eczema demand
AGP
The Business Research Company says the global Adbry/Adtralza market has growth potential through 2030, driven by rising atopic dermatitis cases, broader biologic use and improving reimbursement.
Adynovate market seen growing on hemophilia A demand and R&D spending
AGP
The Business Research Company says the Adynovate (Adynovi) market is set for continued growth through 2035, driven by rising hemophilia A diagnoses, demand for less frequent dosing, and more R&D investment.
ADME toxicology testing market to reach $20.25 billion by 2030
AGP
The ADME toxicology testing market is projected to grow from $11.5 billion in 2025 to $20.25 billion by 2030, driven by rising drug development activity, tighter safety rules and broader use of advanced testing tools.
Montgomery County launches Ride On bus campaign for green businesses
AGP
Bethesda Green and the Montgomery County Department of Environmental Protection launched a monthlong Ride On bus campaign in Rockville on Oct. 29 recognizing certified green businesses.
Aduhelm market report points to aging-driven demand and faster Asia-Pacific growth
AGP
The Business Research Company says the Aduhelm market is expanding as Alzheimer’s cases rise, diagnosis improves and demand grows for disease-modifying therapies.
Adagen market seen growing to $0.13 million by 2030
AGP
The Business Research Company says the global Adagen market is set for steady growth, rising from $0.09 million in 2025 to $0.1 million in 2026 and reaching $0.13 million by 2030. The report points to rising precision medicine use, more rare…
Addison's disease market seen reaching $3.53 billion by 2030
AGP
The Business Research Company projects the global Addison’s disease market will grow from $2.46 billion in 2026 to $3.53 billion by 2030. The report points to rising autoimmune disease rates, broader diagnostic access and newer treatment…
Acute repetitive seizures market seen reaching $5.99 billion by 2030
AGP
The global acute repetitive seizures market is projected to grow from $3.91 billion in 2026 to $5.99 billion by 2030, according to The Business Research Company.
ARF market seen reaching $9.71 billion by 2030
AGP
The acute renal failure market is projected to grow from $6.6 billion in 2025 to $9.71 billion by 2030, driven by higher rates of diabetes, hypertension and chronic kidney disease.
Spartech expands Polycast acrylic capacity for aerospace demand
AGP
Spartech said Oct. 29 it is expanding Polycast acrylic manufacturing capacity across multiple facilities to meet rising aerospace demand.
Sign up for:
Business Post Examiner
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.